At Nemours, we promise to do whatever it takes to treat children as we would our own. When your child comes to Nemours, we know you’re placing your trust in us. This trust and our dedication to improving the health of your child is what inspires us to provide exceptional care and the most satisfying experience possible.
Stories: Patients and families share their experiences.
Quality & Safety: Learn how we track and measure the success of our care.
- Acute Lymphoblastic Leukemia (ALL) Survival Rate
- Giving Even the Sickest Children the Best Chance at Life
Patient Satisfaction: See what families say about our care.
News & Recognition
- Alfred I. duPont Hospital for Children Wins Research Grant From Hyundai Hope On Wheels
- Caitlin Robb Foundation Donates to Cancer Research
- Carper, Carney Announce $4.6 Million for Cancer Research
- Dr. Kolb Appointed to Children's Oncology Group Scientific Council
- Component of Turmeric Shows Promise in Brain Tumor Treatment
- D.O. Believe Foundation Donates $25,000 to Nemours Childhood Cancer Research
- Delaware Health Sciences Alliance Awards Grant to Nemours Center for Childhood Cancer Research
- Hyundai Hope on Wheels Awards Nemours $100,000 Grant
- Jeremy P. Wilson Foundation Donates $20,000 to Nemours Cancer Research
- Joint Cancer Program of Nemours and Wolfson Children's Receives Achievement Award
- Kids' Runway for Research gives $9,000 to Child Cancer Research
- Nanotechnology for Drug Delivery Shows Promise in Treatment of Pediatric Leukemia
- Nemours Receives Donation to Support Cancer Research
- Nemours Researchers Uncover New Evidence of Harmfulness of Secondhand Smoke
- Students Donate Art Work to Nemours/Alfred I. duPont Hospital for Children
- U.S. News & World Report 2011-2012
Delaware Health Sciences Alliance Awards Grant to Nemours Center for Childhood Cancer Research
Newark, DE — The Delaware Health Sciences Alliance (DHSA) has selected three teams of investigators for funding through its pilot grant program. The 18-month awards – for projects addressing hypertension, childhood cancer, and autism – started November 1, 2011.
A team led by Dr. A.J. Rajasekaran, Director, Nemours Center for Childhood Cancer Research, received a $75,000 award to study nanotechnology-based drug delivery for childhood leukemia.
While childhood cancer treatments have improved over the past several decades, with the five-year survival rate now approaching 80%, many survivors are left with chronic health conditions as the result of treatment, including cognitive and emotional issues, fertility problems, and secondary cancers.
This project is aimed at developing a nano-therapeutic mechanism to precisely deliver drugs to cancer cells, thereby minimizing the side effects that damage normal growing cells in children. Dr. Rajasekaran will collaborate with Xinqiao Jia (University of Delaware); Scott Waldman (Thomas Jefferson University); and Robert Witt (Christiana Care) on this project.
The DHSA was established in 2009 with four founding partners:
- Christiana Care Health System
- Nemours/Alfred I. duPont Hospital for Children
- Thomas Jefferson University
- University of Delaware
The alliance allows partner organizations to collaborate and conduct leading-edge biomedical research, to improve the health of Delawareans, and to educate the next generation of health professionals.
Projects were selected based on scientific merit, the potential to lead to a larger proposal for National Institutes of Health (NIH) funding, and the ability of the research team, which must include one investigator from each member institution, to demonstrate successful collaboration among the four institutions.